ロード中...
Total neoadjuvant chemotherapy with FLOT scheme in resectable adenocarcinoma of the gastro-oesophageal junction or gastric adenocarcinoma: impact on pathological complete response and safety
BACKGROUND: Gastric cancer is the fifth cause of cancer incidence worldwide. Multidisciplinary approaches that improve the survival are needed. Perioperative chemotherapies show improvement in pathological complete remission (pCR) and overall survival (OS), but less than 50% of the patients complete...
保存先:
| 出版年: | Ecancermedicalscience |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cancer Intelligence
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7929772/ https://ncbi.nlm.nih.gov/pubmed/33680082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2021.1168 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|